Domain Associates

Domain Associates

U.S-based private equity and venture capital firm investing on life science companies.

Domain Associates is a private equity and venture capital firm that focuses on funding startups in the field of life sciences. The firm was founded in 1985 by Jesse I. Treu. Jim Blair has joined the firm since its inception and has remained as one of the firm’s partner as of February 2019. The firm’s current headquarters is located in New Jersey, but it also has offices in San Diego and Philadelphia.

Funding

In the past, the Domain Associates has invested in companies offering their business services in these fields: pharmaceuticals, diagnostics, and medical devices. The firm has also financed companies seeking various stages of funding: from incubation-stage startups to companies already at the stage of emerging growth

As of February 2019, the firm has raised more than $2.8 billion throughout its funding series. Its last funding series was launched in December 2016, and it managed to obtain $163.6 million. In December 2003 and April 2009 respectively, the firm succeeded in acquiring $500 million for each funding series.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Oraya Therapeutics

Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.

A company focused on development of products to treat central nervous system disorders, pain and rare diseases

Veracyte is a diagnostics company offering genomic tests services

A company developing therapies for inflammation and neurological diseases

Clovis Oncology is a Boulder, Colorado-based biopharmaceutical company developing and commercializing cancer treatments.

A diagnostics company providing real-time biopsy material to guide personalized medicine for cancer patients

A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests

A compant developing nanoscale imaging and analytic platforms to analyze DNA

ChromaCode is a Carlsbad, California-based company developing molecular diagnostics and bioinformatics systems.

A pharmaceutical company engaged in the discovery, development and commercializtion of antibacterials for the treatment of infections

A biotechnology company focused on the discovery and development of protein therapeutics

Sera Prognostics is a Salt Lake City-based manufacturer and supplier of diagnostic tests for possible pregnancy and birth complications.

A company focused on the discovery and development of treatments for rare inherited diseases.

A molecular diagnostics company that develops testing for infecctious diseases

A company focused on the development of immunotherapeutics and preventative vaccines for fungal and bacterial disease

A biopharmaceutical company developing pain management drugs

A company focused on the development proteomics

Benvenue Medical is a healthcare company.

A pharmacological company that develops PARP inhibitors as cancer therapies

A company focused on discovery and development of protein biologics for human therapeutics to treat rare diseases

A biopharmaceutical company focused on developing treatments for inner and middle ear diseases

57 Results
Results per page:
Page 1 of 3

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Domain Partners VIII, L.P.
371,070,000
June 18, 2009
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Brian Dovey

Partner

Brian Halak

Partner

Jesse I. Treu

Founder/Partner Emeritus

Jim Blair

Partner

Kim Kamdar

Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Achillion Pharmaceuticals

Celtaxsys

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.